At present, there are more than 40 products of different specifications sold under the Chang 'ao brand, including seven national second-class new drugs. Sibutramine Hydrochloride Capsule, a national second-class medicine, was included in the innovation fund project of the Ministry of Science and Technology and won the second prize of Nanjing Science and Technology Progress Award. Pantoprazole sodium for injection won the title of excellent new product in Nanjing; 200 1, sibutramine hydrochloride capsules and pantoprazole sodium for injection were recognized as high-tech products in Nanjing. In 2002, sibutramine hydrochloride capsules, clarithromycin dispersible tablets and pantoprazole sodium for injection were recognized as high-tech products in Jiangsu Province.
Scientific and technological progress is the foundation of the company's development. From 200 1, the company established "Nanjing Chang 'ao Pharmaceutical Technology Co., Ltd." with 95% equity. The company implements an internal operation mechanism that meets international standards. Cooperate with drug research and development institutions in the United States, Canada, Switzerland and other countries, and cooperate with Shanghai Institute of Pharmacology, China Academy of Sciences, China Pharmaceutical University and a number of outstanding private scientific research institutes. It has laid a solid foundation for the company's development in the next twenty years. Two new drugs, ZLR-8 (anti-inflammatory and analgesic) and PNA (anti-hepatitis), which have patent rights for compounds, have made breakthroughs. A new drug YC- 12 (antibiotic) was developed, and its antibacterial activity was 4-8 times that of vancomycin, which was listed in the "National 863 Project". The research of three first-class new drugs shows bright prospects.
With scientific and efficient management, strong marketing network and solid drug research institutions, the company has established a competitive advantage in the market. Companies adhere to the "people-oriented", creating a unique management model, scientific and standardized management and operation. Company operators regard honesty as their lifeblood and have a good reputation in Nanjing's medical and financial circles. Provincial and municipal leaders have visited many times and given full affirmation and high praise, and have been rated as advanced enterprises in Nanjing for many times. In 200 1 year, the company was recognized as a high-tech enterprise in Nanjing, a high-tech enterprise in Jiangsu Province in 2002, a private high-tech enterprise in Jiangsu Province in 2003, an advanced technology enterprise with foreign investment in Nanjing in 2004, and a technology-intensive and knowledge-intensive enterprise with foreign investment in Jiangsu Province in 2005.